

ABclonal Biotechnology, a life science tools and services provider, has raised $92.9 million in Series C financing. Sequoia Capital China and LYFE Capital led the round.
Source: Press Release
ABclonal Biotechnology, a life science tools and services provider, has raised $92.9 million in Series C financing.
ABclonal Biotechnology, a life science tools and services provider, has raised $92.9 million in Series C financing. Sequoia Capital China and LYFE Capital led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination